v3.26.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 16,116 $ 10,189
Cost of sales 3,691 2,553
Gross profit 12,425 7,636
Operating expenses:    
Research and development 5,178 3,150
Sales and marketing 10,297 6,739
General and administrative 6,226 3,466
Total operating expenses 21,701 13,355
Loss from operations (9,276) (5,719)
Other income (expense):    
Interest expense (311) (357)
Interest income 891 380
Change in fair value of warrant liabilities 0 (33)
Total other income (expense), net 580 (10)
Net loss (8,696) (5,729)
Net loss and comprehensive loss (8,696) (5,729)
Deemed dividend to preferred stockholders   (584)
Net loss attributable to common stockholders $ (8,696) $ (6,313)
Net loss per share attributable to common stockholders, basic $ (0.32) $ (1.47)
Net loss per share attributable to common stockholders, diluted $ (0.32) $ (1.47)
Weighted-average number of common shares used to compute basic net loss per share 26,835,841 4,299,492
Weighted-average number of common shares used to compute diluted net loss per share 26,835,841 4,299,492